Host genomics: lessons for infectious disease - PHG Foundation (original) (raw)

In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make recommendations to policy influencers and research funders on the opportunities and challenges faced by researchers working to deliver better precision-based approaches for infectious disease management.

These four pathogens, Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Mycobacterial tuberculosis and SARS-CoV-2, continue to have a major impact on global populations.

What is host genomics research?

Infectious diseases elicit different responses among individuals exposed to the same pathogen – some people are more susceptible, and the severity of symptoms varies from person to person. Host genomics research aims to identify genetic variants that explain these differences in response, helping to improve infectious disease prevention and treatment. But, given the limited resources, host genomics research needs to be undertaken in the context of the public health and clinical priorities for each infectious disease.

Key findings in Host genomics: lessons for infectious disease

We advocate a more integrated and holistic approach to infectious disease research.

Policy and research recommendations

To achieve this, we make three high-level recommendations:

Reflecting on where the science falls short, the report highlights for researchers where they might refine their efforts and realise the benefits host genomics research can bring to population health. With its honest appraisal of where this science adds value, Host genomics: lessons for infectious disease can also support funders and policy influencers with decision-making to address the challenges and opportunities identified.